The appointment reinforces DFE Pharma’s commitment to reliable supply, scalable operations and continuous improvement ...
Dipharma has acquired UK-based LogixX Pharma, establishing a direct commercial presence in the UK and creating a platform for ...
Expanded portfolio Includes new droplet digital PCR assays, Reagents and technologies to support oncology research ...
The packaging manufacturer recorded third-quarter revenue of €605m, up 8% year on year, while adjusted EBITDA remained broadly stable at €103m ...
VintaBio’s assignee is seeking bids for its cGMP facility, equipment and proprietary AAV technology as gene therapy contract ...
Precise weighing, automated reporting and tailored handling help pharmaceutical producers reduce waste, streamline compliance ...
The company has been recognised for its end-to-end digital capabilities, AI-enabled portfolio and open Smart Lab Ecosystem in ...
The CDMO is investing $50m in additional solid-phase peptide synthesis capacity and a new commercial manufacturing line at ...
The agency's new biomonitoring study will investigate PFAS exposure across the UK, providing evidence as pharmaceutical ...
The new probes advance OGT’s transition of its CytoCell portfolio from IVDD ahead of the December 2028 Class C deadline, ...
Pharmaceutical manufacturers already serialise medicines using 2D codes to meet regulatory requirements, but a 2D code can be so much more than a tick box for compliance, explains Ian Chapman, Strateg ...
Merck KGaA will sell its US CDMO business to Lonza in a deal worth hundreds of millions of Swiss francs, expanding Lonza's US manufacturing footprint and marking a strategic shift for Merck Merck KGaA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results